Loading…
Hydroxytyrosol prevents diet-induced metabolic syndrome and attenuates mitochondrial abnormalities in obese mice
A Mediterranean diet rich in olive oil has profound influence on health outcomes including metabolic syndrome. However, the active compound and detailed mechanisms still remain unclear. Hydroxytyrosol (HT), a major polyphenolic compound in virgin olive oil, has received increased attention for its a...
Saved in:
Published in: | Free radical biology & medicine 2014-02, Vol.67, p.396-407 |
---|---|
Main Authors: | , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c416t-6e0198f870243c127c7664748ba42d3044f0457379a020be95847889e63b002e3 |
---|---|
cites | cdi_FETCH-LOGICAL-c416t-6e0198f870243c127c7664748ba42d3044f0457379a020be95847889e63b002e3 |
container_end_page | 407 |
container_issue | |
container_start_page | 396 |
container_title | Free radical biology & medicine |
container_volume | 67 |
creator | Cao, Ke Xu, Jie Zou, Xuan Li, Yuan Chen, Cong Zheng, Adi Li, Hao Li, Hua Szeto, Ignatius Man-Yau Shi, Yujie Long, Jiangang Liu, Jiankang Feng, Zhihui |
description | A Mediterranean diet rich in olive oil has profound influence on health outcomes including metabolic syndrome. However, the active compound and detailed mechanisms still remain unclear. Hydroxytyrosol (HT), a major polyphenolic compound in virgin olive oil, has received increased attention for its antioxidative activity and regulation of mitochondrial function. Here, we investigated whether HT is the active compound in olive oil exerting a protective effect against metabolic syndrome. In this study, we show that HT could prevent high-fat-diet (HFD)-induced obesity, hyperglycemia, hyperlipidemia, and insulin resistance in C57BL/6J mice after 17 weeks supplementation. Within liver and skeletal muscle tissues, HT could decrease HFD-induced lipid deposits through inhibition of the SREBP-1c/FAS pathway, ameliorate HFD-induced oxidative stress by enhancing antioxidant enzyme activities, normalize expression of mitochondrial complex subunits and mitochondrial fission marker Drp1, and eventually inhibit apoptosis activation. Moreover, in muscle tissue, the levels of mitochondrial carbonyl protein were decreased and mitochondrial complex activities were significantly improved by HT supplementation. In db/db mice, HT significantly decreased fasting glucose, similar to metformin. Notably, HT decreased serum lipid, at which metformin failed. Also, HT was more effective at decreasing the oxidation levels of lipids and proteins in both liver and muscle tissue. Similar to the results in the HFD model, HT decreased muscle mitochondrial carbonyl protein levels and improved mitochondrial complex activities in db/db mice. Our study links the olive oil component HT to diabetes and metabolic disease through changes that are not limited to decreases in oxidative stress, suggesting a potential pharmaceutical or clinical use of HT in metabolic syndrome treatment.
•High-fat-diet (HFD)-induced metabolic syndrome was prevented by hydroxytyrosol.•Hydroxytyrosol (HT) could inhibit the SREBP-1c/FAS pathway in mouse liver and muscle.•HFD-induced oxidative stress and mitochondrial abnormalities were eliminated by HT.•HT improved lipid and glucose metabolism in db/db mice.•HT reduced oxidative damage and improved mitochondrial activity in db/db mice. |
doi_str_mv | 10.1016/j.freeradbiomed.2013.11.029 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1687662343</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0891584913015347</els_id><sourcerecordid>1687662343</sourcerecordid><originalsourceid>FETCH-LOGICAL-c416t-6e0198f870243c127c7664748ba42d3044f0457379a020be95847889e63b002e3</originalsourceid><addsrcrecordid>eNqNkctu1DAUQC0EokPbX0CW2LBJsGOPH2KFqtIiVWIDa8uxb4RHiT3YTkX-Ho-mXXQFq7u45z4PQh8o6Smh4tOhnzJAtn4MaQHfD4SyntKeDPoV2lElWcf3WrxGO6I07faK6wv0rpQDIYTvmXqLLgbOqGCS7tDxfvM5_dnqllNJMz5meIRYC_YBaheiXx14vEC1Y5qDw2WLjV8A2-ixrRXiaisUvISa3K_UksHO2I4x5cXOoYaWCxGnEQo0yMEVejPZucD1U7xEP7_e_ri57x6-3327-fLQOU5F7QQQqtWkJGm7OjpIJ4XgkqvR8sEzwvnUjpFMaksGMoJuZ0qlNAg2EjIAu0Qfz32POf1eoVSzhOJgnm2EtBZDhWodB8bZv1GuNd3ztkpDP59R195VMkzmmMNi82YoMSc75mBe2DEnO4ZS0-y06vdPg9bxlHuufdbRgNszAO0zjwGyKS5AbApCBleNT-G_Bv0FEi-pRQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1499154702</pqid></control><display><type>article</type><title>Hydroxytyrosol prevents diet-induced metabolic syndrome and attenuates mitochondrial abnormalities in obese mice</title><source>ScienceDirect Freedom Collection</source><creator>Cao, Ke ; Xu, Jie ; Zou, Xuan ; Li, Yuan ; Chen, Cong ; Zheng, Adi ; Li, Hao ; Li, Hua ; Szeto, Ignatius Man-Yau ; Shi, Yujie ; Long, Jiangang ; Liu, Jiankang ; Feng, Zhihui</creator><creatorcontrib>Cao, Ke ; Xu, Jie ; Zou, Xuan ; Li, Yuan ; Chen, Cong ; Zheng, Adi ; Li, Hao ; Li, Hua ; Szeto, Ignatius Man-Yau ; Shi, Yujie ; Long, Jiangang ; Liu, Jiankang ; Feng, Zhihui</creatorcontrib><description>A Mediterranean diet rich in olive oil has profound influence on health outcomes including metabolic syndrome. However, the active compound and detailed mechanisms still remain unclear. Hydroxytyrosol (HT), a major polyphenolic compound in virgin olive oil, has received increased attention for its antioxidative activity and regulation of mitochondrial function. Here, we investigated whether HT is the active compound in olive oil exerting a protective effect against metabolic syndrome. In this study, we show that HT could prevent high-fat-diet (HFD)-induced obesity, hyperglycemia, hyperlipidemia, and insulin resistance in C57BL/6J mice after 17 weeks supplementation. Within liver and skeletal muscle tissues, HT could decrease HFD-induced lipid deposits through inhibition of the SREBP-1c/FAS pathway, ameliorate HFD-induced oxidative stress by enhancing antioxidant enzyme activities, normalize expression of mitochondrial complex subunits and mitochondrial fission marker Drp1, and eventually inhibit apoptosis activation. Moreover, in muscle tissue, the levels of mitochondrial carbonyl protein were decreased and mitochondrial complex activities were significantly improved by HT supplementation. In db/db mice, HT significantly decreased fasting glucose, similar to metformin. Notably, HT decreased serum lipid, at which metformin failed. Also, HT was more effective at decreasing the oxidation levels of lipids and proteins in both liver and muscle tissue. Similar to the results in the HFD model, HT decreased muscle mitochondrial carbonyl protein levels and improved mitochondrial complex activities in db/db mice. Our study links the olive oil component HT to diabetes and metabolic disease through changes that are not limited to decreases in oxidative stress, suggesting a potential pharmaceutical or clinical use of HT in metabolic syndrome treatment.
•High-fat-diet (HFD)-induced metabolic syndrome was prevented by hydroxytyrosol.•Hydroxytyrosol (HT) could inhibit the SREBP-1c/FAS pathway in mouse liver and muscle.•HFD-induced oxidative stress and mitochondrial abnormalities were eliminated by HT.•HT improved lipid and glucose metabolism in db/db mice.•HT reduced oxidative damage and improved mitochondrial activity in db/db mice.</description><identifier>ISSN: 0891-5849</identifier><identifier>EISSN: 1873-4596</identifier><identifier>DOI: 10.1016/j.freeradbiomed.2013.11.029</identifier><identifier>PMID: 24316371</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Animals ; Antioxidants - pharmacology ; Apoptosis ; Blood Glucose - metabolism ; Diet, High-Fat ; Dietary Fats - adverse effects ; Dynamins - genetics ; Dynamins - metabolism ; fas Receptor - genetics ; fas Receptor - metabolism ; Free radicals ; Gene Expression Regulation ; Hydroxytyrosol ; Hyperglycemia - drug therapy ; Hyperglycemia - etiology ; Hyperglycemia - metabolism ; Hyperglycemia - pathology ; Hyperlipidemias - drug therapy ; Hyperlipidemias - etiology ; Hyperlipidemias - metabolism ; Hyperlipidemias - pathology ; Insulin Resistance ; Lipid Metabolism - drug effects ; Male ; Metabolic Syndrome - drug therapy ; Metabolic Syndrome - etiology ; Metabolic Syndrome - metabolism ; Metabolic Syndrome - pathology ; Mice ; Mice, Inbred C57BL ; Mitochondria - drug effects ; Mitochondria - metabolism ; Mitochondria - pathology ; Mitochondrial abnormalities ; Obesity - drug therapy ; Obesity - etiology ; Obesity - metabolism ; Obesity - pathology ; Olea ; Oxidative stress ; Oxidative Stress - drug effects ; Phenylethyl Alcohol - analogs & derivatives ; Phenylethyl Alcohol - pharmacology ; Protein Carbonylation ; Signal Transduction ; Sterol Regulatory Element Binding Protein 1 - genetics ; Sterol Regulatory Element Binding Protein 1 - metabolism</subject><ispartof>Free radical biology & medicine, 2014-02, Vol.67, p.396-407</ispartof><rights>2013 Elsevier Inc.</rights><rights>Copyright © 2013 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c416t-6e0198f870243c127c7664748ba42d3044f0457379a020be95847889e63b002e3</citedby><cites>FETCH-LOGICAL-c416t-6e0198f870243c127c7664748ba42d3044f0457379a020be95847889e63b002e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24316371$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cao, Ke</creatorcontrib><creatorcontrib>Xu, Jie</creatorcontrib><creatorcontrib>Zou, Xuan</creatorcontrib><creatorcontrib>Li, Yuan</creatorcontrib><creatorcontrib>Chen, Cong</creatorcontrib><creatorcontrib>Zheng, Adi</creatorcontrib><creatorcontrib>Li, Hao</creatorcontrib><creatorcontrib>Li, Hua</creatorcontrib><creatorcontrib>Szeto, Ignatius Man-Yau</creatorcontrib><creatorcontrib>Shi, Yujie</creatorcontrib><creatorcontrib>Long, Jiangang</creatorcontrib><creatorcontrib>Liu, Jiankang</creatorcontrib><creatorcontrib>Feng, Zhihui</creatorcontrib><title>Hydroxytyrosol prevents diet-induced metabolic syndrome and attenuates mitochondrial abnormalities in obese mice</title><title>Free radical biology & medicine</title><addtitle>Free Radic Biol Med</addtitle><description>A Mediterranean diet rich in olive oil has profound influence on health outcomes including metabolic syndrome. However, the active compound and detailed mechanisms still remain unclear. Hydroxytyrosol (HT), a major polyphenolic compound in virgin olive oil, has received increased attention for its antioxidative activity and regulation of mitochondrial function. Here, we investigated whether HT is the active compound in olive oil exerting a protective effect against metabolic syndrome. In this study, we show that HT could prevent high-fat-diet (HFD)-induced obesity, hyperglycemia, hyperlipidemia, and insulin resistance in C57BL/6J mice after 17 weeks supplementation. Within liver and skeletal muscle tissues, HT could decrease HFD-induced lipid deposits through inhibition of the SREBP-1c/FAS pathway, ameliorate HFD-induced oxidative stress by enhancing antioxidant enzyme activities, normalize expression of mitochondrial complex subunits and mitochondrial fission marker Drp1, and eventually inhibit apoptosis activation. Moreover, in muscle tissue, the levels of mitochondrial carbonyl protein were decreased and mitochondrial complex activities were significantly improved by HT supplementation. In db/db mice, HT significantly decreased fasting glucose, similar to metformin. Notably, HT decreased serum lipid, at which metformin failed. Also, HT was more effective at decreasing the oxidation levels of lipids and proteins in both liver and muscle tissue. Similar to the results in the HFD model, HT decreased muscle mitochondrial carbonyl protein levels and improved mitochondrial complex activities in db/db mice. Our study links the olive oil component HT to diabetes and metabolic disease through changes that are not limited to decreases in oxidative stress, suggesting a potential pharmaceutical or clinical use of HT in metabolic syndrome treatment.
•High-fat-diet (HFD)-induced metabolic syndrome was prevented by hydroxytyrosol.•Hydroxytyrosol (HT) could inhibit the SREBP-1c/FAS pathway in mouse liver and muscle.•HFD-induced oxidative stress and mitochondrial abnormalities were eliminated by HT.•HT improved lipid and glucose metabolism in db/db mice.•HT reduced oxidative damage and improved mitochondrial activity in db/db mice.</description><subject>Animals</subject><subject>Antioxidants - pharmacology</subject><subject>Apoptosis</subject><subject>Blood Glucose - metabolism</subject><subject>Diet, High-Fat</subject><subject>Dietary Fats - adverse effects</subject><subject>Dynamins - genetics</subject><subject>Dynamins - metabolism</subject><subject>fas Receptor - genetics</subject><subject>fas Receptor - metabolism</subject><subject>Free radicals</subject><subject>Gene Expression Regulation</subject><subject>Hydroxytyrosol</subject><subject>Hyperglycemia - drug therapy</subject><subject>Hyperglycemia - etiology</subject><subject>Hyperglycemia - metabolism</subject><subject>Hyperglycemia - pathology</subject><subject>Hyperlipidemias - drug therapy</subject><subject>Hyperlipidemias - etiology</subject><subject>Hyperlipidemias - metabolism</subject><subject>Hyperlipidemias - pathology</subject><subject>Insulin Resistance</subject><subject>Lipid Metabolism - drug effects</subject><subject>Male</subject><subject>Metabolic Syndrome - drug therapy</subject><subject>Metabolic Syndrome - etiology</subject><subject>Metabolic Syndrome - metabolism</subject><subject>Metabolic Syndrome - pathology</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Mitochondria - drug effects</subject><subject>Mitochondria - metabolism</subject><subject>Mitochondria - pathology</subject><subject>Mitochondrial abnormalities</subject><subject>Obesity - drug therapy</subject><subject>Obesity - etiology</subject><subject>Obesity - metabolism</subject><subject>Obesity - pathology</subject><subject>Olea</subject><subject>Oxidative stress</subject><subject>Oxidative Stress - drug effects</subject><subject>Phenylethyl Alcohol - analogs & derivatives</subject><subject>Phenylethyl Alcohol - pharmacology</subject><subject>Protein Carbonylation</subject><subject>Signal Transduction</subject><subject>Sterol Regulatory Element Binding Protein 1 - genetics</subject><subject>Sterol Regulatory Element Binding Protein 1 - metabolism</subject><issn>0891-5849</issn><issn>1873-4596</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNqNkctu1DAUQC0EokPbX0CW2LBJsGOPH2KFqtIiVWIDa8uxb4RHiT3YTkX-Ho-mXXQFq7u45z4PQh8o6Smh4tOhnzJAtn4MaQHfD4SyntKeDPoV2lElWcf3WrxGO6I07faK6wv0rpQDIYTvmXqLLgbOqGCS7tDxfvM5_dnqllNJMz5meIRYC_YBaheiXx14vEC1Y5qDw2WLjV8A2-ixrRXiaisUvISa3K_UksHO2I4x5cXOoYaWCxGnEQo0yMEVejPZucD1U7xEP7_e_ri57x6-3327-fLQOU5F7QQQqtWkJGm7OjpIJ4XgkqvR8sEzwvnUjpFMaksGMoJuZ0qlNAg2EjIAu0Qfz32POf1eoVSzhOJgnm2EtBZDhWodB8bZv1GuNd3ztkpDP59R195VMkzmmMNi82YoMSc75mBe2DEnO4ZS0-y06vdPg9bxlHuufdbRgNszAO0zjwGyKS5AbApCBleNT-G_Bv0FEi-pRQ</recordid><startdate>201402</startdate><enddate>201402</enddate><creator>Cao, Ke</creator><creator>Xu, Jie</creator><creator>Zou, Xuan</creator><creator>Li, Yuan</creator><creator>Chen, Cong</creator><creator>Zheng, Adi</creator><creator>Li, Hao</creator><creator>Li, Hua</creator><creator>Szeto, Ignatius Man-Yau</creator><creator>Shi, Yujie</creator><creator>Long, Jiangang</creator><creator>Liu, Jiankang</creator><creator>Feng, Zhihui</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7U7</scope><scope>C1K</scope></search><sort><creationdate>201402</creationdate><title>Hydroxytyrosol prevents diet-induced metabolic syndrome and attenuates mitochondrial abnormalities in obese mice</title><author>Cao, Ke ; Xu, Jie ; Zou, Xuan ; Li, Yuan ; Chen, Cong ; Zheng, Adi ; Li, Hao ; Li, Hua ; Szeto, Ignatius Man-Yau ; Shi, Yujie ; Long, Jiangang ; Liu, Jiankang ; Feng, Zhihui</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c416t-6e0198f870243c127c7664748ba42d3044f0457379a020be95847889e63b002e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Animals</topic><topic>Antioxidants - pharmacology</topic><topic>Apoptosis</topic><topic>Blood Glucose - metabolism</topic><topic>Diet, High-Fat</topic><topic>Dietary Fats - adverse effects</topic><topic>Dynamins - genetics</topic><topic>Dynamins - metabolism</topic><topic>fas Receptor - genetics</topic><topic>fas Receptor - metabolism</topic><topic>Free radicals</topic><topic>Gene Expression Regulation</topic><topic>Hydroxytyrosol</topic><topic>Hyperglycemia - drug therapy</topic><topic>Hyperglycemia - etiology</topic><topic>Hyperglycemia - metabolism</topic><topic>Hyperglycemia - pathology</topic><topic>Hyperlipidemias - drug therapy</topic><topic>Hyperlipidemias - etiology</topic><topic>Hyperlipidemias - metabolism</topic><topic>Hyperlipidemias - pathology</topic><topic>Insulin Resistance</topic><topic>Lipid Metabolism - drug effects</topic><topic>Male</topic><topic>Metabolic Syndrome - drug therapy</topic><topic>Metabolic Syndrome - etiology</topic><topic>Metabolic Syndrome - metabolism</topic><topic>Metabolic Syndrome - pathology</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Mitochondria - drug effects</topic><topic>Mitochondria - metabolism</topic><topic>Mitochondria - pathology</topic><topic>Mitochondrial abnormalities</topic><topic>Obesity - drug therapy</topic><topic>Obesity - etiology</topic><topic>Obesity - metabolism</topic><topic>Obesity - pathology</topic><topic>Olea</topic><topic>Oxidative stress</topic><topic>Oxidative Stress - drug effects</topic><topic>Phenylethyl Alcohol - analogs & derivatives</topic><topic>Phenylethyl Alcohol - pharmacology</topic><topic>Protein Carbonylation</topic><topic>Signal Transduction</topic><topic>Sterol Regulatory Element Binding Protein 1 - genetics</topic><topic>Sterol Regulatory Element Binding Protein 1 - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cao, Ke</creatorcontrib><creatorcontrib>Xu, Jie</creatorcontrib><creatorcontrib>Zou, Xuan</creatorcontrib><creatorcontrib>Li, Yuan</creatorcontrib><creatorcontrib>Chen, Cong</creatorcontrib><creatorcontrib>Zheng, Adi</creatorcontrib><creatorcontrib>Li, Hao</creatorcontrib><creatorcontrib>Li, Hua</creatorcontrib><creatorcontrib>Szeto, Ignatius Man-Yau</creatorcontrib><creatorcontrib>Shi, Yujie</creatorcontrib><creatorcontrib>Long, Jiangang</creatorcontrib><creatorcontrib>Liu, Jiankang</creatorcontrib><creatorcontrib>Feng, Zhihui</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><jtitle>Free radical biology & medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cao, Ke</au><au>Xu, Jie</au><au>Zou, Xuan</au><au>Li, Yuan</au><au>Chen, Cong</au><au>Zheng, Adi</au><au>Li, Hao</au><au>Li, Hua</au><au>Szeto, Ignatius Man-Yau</au><au>Shi, Yujie</au><au>Long, Jiangang</au><au>Liu, Jiankang</au><au>Feng, Zhihui</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hydroxytyrosol prevents diet-induced metabolic syndrome and attenuates mitochondrial abnormalities in obese mice</atitle><jtitle>Free radical biology & medicine</jtitle><addtitle>Free Radic Biol Med</addtitle><date>2014-02</date><risdate>2014</risdate><volume>67</volume><spage>396</spage><epage>407</epage><pages>396-407</pages><issn>0891-5849</issn><eissn>1873-4596</eissn><abstract>A Mediterranean diet rich in olive oil has profound influence on health outcomes including metabolic syndrome. However, the active compound and detailed mechanisms still remain unclear. Hydroxytyrosol (HT), a major polyphenolic compound in virgin olive oil, has received increased attention for its antioxidative activity and regulation of mitochondrial function. Here, we investigated whether HT is the active compound in olive oil exerting a protective effect against metabolic syndrome. In this study, we show that HT could prevent high-fat-diet (HFD)-induced obesity, hyperglycemia, hyperlipidemia, and insulin resistance in C57BL/6J mice after 17 weeks supplementation. Within liver and skeletal muscle tissues, HT could decrease HFD-induced lipid deposits through inhibition of the SREBP-1c/FAS pathway, ameliorate HFD-induced oxidative stress by enhancing antioxidant enzyme activities, normalize expression of mitochondrial complex subunits and mitochondrial fission marker Drp1, and eventually inhibit apoptosis activation. Moreover, in muscle tissue, the levels of mitochondrial carbonyl protein were decreased and mitochondrial complex activities were significantly improved by HT supplementation. In db/db mice, HT significantly decreased fasting glucose, similar to metformin. Notably, HT decreased serum lipid, at which metformin failed. Also, HT was more effective at decreasing the oxidation levels of lipids and proteins in both liver and muscle tissue. Similar to the results in the HFD model, HT decreased muscle mitochondrial carbonyl protein levels and improved mitochondrial complex activities in db/db mice. Our study links the olive oil component HT to diabetes and metabolic disease through changes that are not limited to decreases in oxidative stress, suggesting a potential pharmaceutical or clinical use of HT in metabolic syndrome treatment.
•High-fat-diet (HFD)-induced metabolic syndrome was prevented by hydroxytyrosol.•Hydroxytyrosol (HT) could inhibit the SREBP-1c/FAS pathway in mouse liver and muscle.•HFD-induced oxidative stress and mitochondrial abnormalities were eliminated by HT.•HT improved lipid and glucose metabolism in db/db mice.•HT reduced oxidative damage and improved mitochondrial activity in db/db mice.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>24316371</pmid><doi>10.1016/j.freeradbiomed.2013.11.029</doi><tpages>12</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0891-5849 |
ispartof | Free radical biology & medicine, 2014-02, Vol.67, p.396-407 |
issn | 0891-5849 1873-4596 |
language | eng |
recordid | cdi_proquest_miscellaneous_1687662343 |
source | ScienceDirect Freedom Collection |
subjects | Animals Antioxidants - pharmacology Apoptosis Blood Glucose - metabolism Diet, High-Fat Dietary Fats - adverse effects Dynamins - genetics Dynamins - metabolism fas Receptor - genetics fas Receptor - metabolism Free radicals Gene Expression Regulation Hydroxytyrosol Hyperglycemia - drug therapy Hyperglycemia - etiology Hyperglycemia - metabolism Hyperglycemia - pathology Hyperlipidemias - drug therapy Hyperlipidemias - etiology Hyperlipidemias - metabolism Hyperlipidemias - pathology Insulin Resistance Lipid Metabolism - drug effects Male Metabolic Syndrome - drug therapy Metabolic Syndrome - etiology Metabolic Syndrome - metabolism Metabolic Syndrome - pathology Mice Mice, Inbred C57BL Mitochondria - drug effects Mitochondria - metabolism Mitochondria - pathology Mitochondrial abnormalities Obesity - drug therapy Obesity - etiology Obesity - metabolism Obesity - pathology Olea Oxidative stress Oxidative Stress - drug effects Phenylethyl Alcohol - analogs & derivatives Phenylethyl Alcohol - pharmacology Protein Carbonylation Signal Transduction Sterol Regulatory Element Binding Protein 1 - genetics Sterol Regulatory Element Binding Protein 1 - metabolism |
title | Hydroxytyrosol prevents diet-induced metabolic syndrome and attenuates mitochondrial abnormalities in obese mice |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T14%3A08%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hydroxytyrosol%20prevents%20diet-induced%20metabolic%20syndrome%20and%20attenuates%20mitochondrial%20abnormalities%20in%20obese%20mice&rft.jtitle=Free%20radical%20biology%20&%20medicine&rft.au=Cao,%20Ke&rft.date=2014-02&rft.volume=67&rft.spage=396&rft.epage=407&rft.pages=396-407&rft.issn=0891-5849&rft.eissn=1873-4596&rft_id=info:doi/10.1016/j.freeradbiomed.2013.11.029&rft_dat=%3Cproquest_cross%3E1687662343%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c416t-6e0198f870243c127c7664748ba42d3044f0457379a020be95847889e63b002e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1499154702&rft_id=info:pmid/24316371&rfr_iscdi=true |